These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
119 related articles for article (PubMed ID: 38712471)
1. Diagnostic value of Kim SY; Crook D; Rosskopf J; Lee JH Head Neck; 2024 Sep; 46(9):2284-2291. PubMed ID: 38712471 [TBL] [Abstract][Full Text] [Related]
2. Comparison of diffusion-weighted MR imaging and Schroeder C; Lee JH; Tetzner U; Seidel S; Kim SY Eur J Radiol; 2020 Sep; 130():109157. PubMed ID: 32652403 [TBL] [Abstract][Full Text] [Related]
3. Prognostic value of Lee JR; Almuhaimid TM; Roh JL; Oh JS; Kim SJ; Kim JS; Choi SH; Nam SY; Kim SY J Surg Oncol; 2018 Sep; 118(4):644-650. PubMed ID: 30132891 [TBL] [Abstract][Full Text] [Related]
4. Correlations between DW-MRI and Connor S; Sit C; Anjari M; Szyszko T; Dunn J; Pai I; Cook G; Goh V Cancer Rep (Hoboken); 2021 Aug; 4(4):e1360. PubMed ID: 33960739 [TBL] [Abstract][Full Text] [Related]
5. Detection of residual head and neck squamous cell carcinoma after (chemo)radiotherapy: a pilot study assessing the value of diffusion-weighted magnetic resonance imaging as an adjunct to PET-CT using Noij DP; Jagesar VA; de Graaf P; de Jong MC; Hoekstra OS; de Bree R; Castelijns JA Oral Surg Oral Med Oral Pathol Oral Radiol; 2017 Sep; 124(3):296-305.e2. PubMed ID: 28539202 [TBL] [Abstract][Full Text] [Related]
6. Diffusion-weighted MR imaging including bi-exponential fitting for the detection of recurrent or residual tumour after (chemo)radiotherapy for laryngeal and hypopharyngeal cancers. Tshering Vogel DW; Zbaeren P; Geretschlaeger A; Vermathen P; De Keyzer F; Thoeny HC Eur Radiol; 2013 Feb; 23(2):562-9. PubMed ID: 22865270 [TBL] [Abstract][Full Text] [Related]
7. Use of Diffusion-Weighted Imaging and Noij DP; Martens RM; Koopman T; Hoekstra OS; Comans EFI; Zwezerijnen B; de Bree R; de Graaf P; Castelijns JA Clin Oncol (R Coll Radiol); 2018 Dec; 30(12):780-792. PubMed ID: 30318343 [TBL] [Abstract][Full Text] [Related]
8. [Diagnosis with (18)F-FDG PET scan after larynx preservation by primary radiochemotherapy]. Dietz A; Rudat V; Harms W; Jungehülsing M; Dollner R; Henze M HNO; 2004 Jan; 52(1):38-44. PubMed ID: 14740113 [TBL] [Abstract][Full Text] [Related]
9. Evaluation of 18F-FDG PET/CT and CT/MRI with histopathologic correlation in patients undergoing salvage surgery for head and neck squamous cell carcinoma. Kim SY; Kim JS; Yi JS; Lee JH; Choi SH; Nam SY; Cho KJ; Lee SW; Kim SB; Roh JL Ann Surg Oncol; 2011 Sep; 18(9):2579-84. PubMed ID: 21409485 [TBL] [Abstract][Full Text] [Related]
10. Evaluation of 18F-FDG PET/CT and CT/MRI with histopathologic correlation in patients undergoing central compartment neck dissection for squamous cell carcinoma of the larynx, hypopharynx, and esophagus. Kim JW; Roh JL; Kim JS; Lee JH; Cho KJ; Choi SH; Nam SY; Kim SY Oral Oncol; 2013 May; 49(5):449-53. PubMed ID: 23321549 [TBL] [Abstract][Full Text] [Related]
11. The detection of local recurrent head and neck cancer with fluorine-18 fluorodeoxyglucose dual-head positron emission tomography. Stokkel MP; Terhaard CH; Hordijk GJ; van Rijk PP Eur J Nucl Med; 1999 Jul; 26(7):767-73. PubMed ID: 10398825 [TBL] [Abstract][Full Text] [Related]
12. Predictive value of quantitative diffusion-weighted imaging and 18-F-FDG-PET in head and neck squamous cell carcinoma treated by (chemo)radiotherapy. Martens RM; Noij DP; Koopman T; Zwezerijnen B; Heymans M; de Jong MC; Hoekstra OS; Vergeer MR; de Bree R; Leemans CR; de Graaf P; Boellaard R; Castelijns JA Eur J Radiol; 2019 Apr; 113():39-50. PubMed ID: 30927958 [TBL] [Abstract][Full Text] [Related]
13. Prospective comparative study of MRI including diffusion-weighted images versus FDG PET-CT for the detection of recurrent head and neck squamous cell carcinomas after (chemo)radiotherapy. Driessen JP; Peltenburg B; Philippens MEP; Huijbregts JE; Pameijer FA; de Bree R; Janssen LM; Terhaard CHJ Eur J Radiol; 2019 Feb; 111():62-67. PubMed ID: 30691667 [TBL] [Abstract][Full Text] [Related]
14. Prospective study of [18F]fluorodeoxyglucose positron emission tomography and computed tomography and magnetic resonance imaging in oral cavity squamous cell carcinoma with palpably negative neck. Ng SH; Yen TC; Chang JT; Chan SC; Ko SF; Wang HM; Lee LY; Kang CJ; Wong AM; Liao CT J Clin Oncol; 2006 Sep; 24(27):4371-6. PubMed ID: 16983105 [TBL] [Abstract][Full Text] [Related]
15. Diffusion-weighted MRI and Xu X; Sun ZY; Wu HW; Zhang CP; Hu B; Rong L; Chen HY; Xie HY; Wang YM; Lin HP; Bai YR; Ye Q; Ma XM Radiat Oncol; 2021 Jul; 16(1):132. PubMed ID: 34281566 [TBL] [Abstract][Full Text] [Related]
17. Kim SA; Roh JL; Kim JS; Lee JH; Lee SH; Choi SH; Nam SY; Kim SY Eur J Cancer; 2017 Feb; 72():62-70. PubMed ID: 28027517 [TBL] [Abstract][Full Text] [Related]
18. Dynamic contrast-enhanced MRI, diffusion-weighted MRI and Ng SH; Liao CT; Lin CY; Chan SC; Lin YC; Yen TC; Chang JT; Ko SF; Fan KH; Wang HM; Yang LY; Wang JJ Eur Radiol; 2016 Nov; 26(11):4162-4172. PubMed ID: 26911889 [TBL] [Abstract][Full Text] [Related]
19. PET-CT detection of local residual laryngeal carcinoma after definitive (chemo)radiotherapy. Sistonen HJ; Ilmarinen T; Atula T; Aro K; Schildt J; Markkola A BMC Cancer; 2023 Apr; 23(1):358. PubMed ID: 37072716 [TBL] [Abstract][Full Text] [Related]
20. The Predictive Value of Early Assessment After 1 Cycle of Induction Chemotherapy with 18F-FDG PET/CT and Diffusion-Weighted MRI for Response to Radical Chemoradiotherapy in Head and Neck Squamous Cell Carcinoma. Wong KH; Panek R; Welsh L; Mcquaid D; Dunlop A; Riddell A; Murray I; Du Y; Chua S; Koh DM; Bhide S; Nutting C; Oyen WJ; Harrington K; Newbold KL J Nucl Med; 2016 Dec; 57(12):1843-1850. PubMed ID: 27417648 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]